HopeStage
Back to overview

ADHD studies

Topics
More filters

ADHD

Attention-deficit/hyperactivity disorder (ADHD) involves persistent difficulties with attention, impulsivity or restlessness that can affect everyday life.

1811studies shown
Showing 1,201-1,212 of 1,811
Drug study icon
TerminatedNCT02827513

Study to Investigate the Safety, Tolerance, Food Effect, Pharmacokinetics and Pharmacodynamics of Single and Multiple Doses of Extended Release Formulations of Centanafadine (CTN) in Young Healthy Subjects

Official study title

A Phase 1 Study to Investigate the Safety, Tolerance, Food Effect, Pharmacokinetics and Pharmacodynamics of Single and Multiple Doses of Extended Release Formulations of Centanafadine (CTN) (Formerly Called EB-1020) in Young Healthy Subjects

This study ended early.

In Melbourne
ADHDMedication studyAges 18–45
Countries
Australia
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc. (Pharmaceutical company)
Behavioral study icon
CompletedNCT04186312

A Psychosocial Treatment Program for College Students (ACCESS)

Official study title

Improving the Educational and Social-Emotional Functioning of College Students With ADHD

This study has finished and is no longer accepting participants.

Location not clearly listed
ADHDBehavioural studyAges 18–30
Countries
Sponsor
University of North Carolina, Greensboro
Other study type icon
CompletedNCT01932398

A Study on the Inter-Hemispheric Alpha Ratio in Kids With ADHD (SHARK)

Official study title

Posterior Alpha Oscillations as an Index for the Attentional Bias in Children With Attentional Deficit Hyperactivity Disorder

This study has finished and is no longer accepting participants.

In Nijmegen
ADHDObservational studyAges 84–95 months
Countries
Netherlands
Sponsor
Radboud University Medical Center
Other study type icon
CompletedNCT00302380

Safety study of Safety and Dopamine Transporter Binding Properties of C-11 Altropane in ADHD

Official study title

An Open Label Phase I/II Study of the Safety and Dopamine Transporter Binding Properties of C-11 Altropane in Normal Human Subjects and in Subjects With ADHD

This study has finished and is no longer accepting participants.

Location not clearly listed
ADHDObservational studyAges 18 months–55 years
Countries
Sponsor
Massachusetts General Hospital (Hospital / academic medical center)
Drug study icon
CompletedNCT00517647

Atomoxetine Study in Preschool Children With ADHD

Official study title

Atomoxetine Pilot Study in Preschool Children With ADHD

This study has finished and is no longer accepting participants.

In Tucson
ADHDMedication studyAges 3–5
Countries
United States
Sponsor
University of Arizona
Drug study icon
CompletedNCT01727414

Attention Deficit Disorder Medication Response Study

Official study title

Medication Response in Children With Predominately Inattentive Type ADHD

This study has finished and is no longer accepting participants.

In Cincinnati
ADHDMedication studyAges 7–11
Countries
United States
Sponsor
Children's Hospital Medical Center, Cincinnati
Behavioral study icon
CompletedNCT06770036

Caregiver Implementation Strategies Field Pre-Test

Official study title

Implementation Strategies for Caregiver and Teacher Use of Behavioral Interventions With ADHD: A Pilot Study, Aim 1

This study has finished and is no longer accepting participants.

In Philadelphia
ADHDBehavioural studyAges 4+
Countries
United States
Sponsor
Children's Hospital of Philadelphia
Behavioral study icon
CompletedNCT01133418

Cognitive Training study

Official study title

Efficacy of a Cognitive Training Intervention for Children With ADHD

This study has finished and is no longer accepting participants.

In Cincinnati
ADHDInterventional studyAges 7–12
Countries
United States
Sponsor
Children's Hospital Medical Center, Cincinnati
Drug study icon
CompletedNCT00799487

CONCERTA Lab School Study

Official study title

Double-Blind, Randomized, Placebo-Controlled, Crossover Study Evaluating the Academic, Behavioral and Cognitive Effects of CONCERTA on Older Children With ADHD (The ABC Study)

This study has finished and is no longer accepting participants.

Multiple locations, including Little Rock
ADHDMedication studyAges 9–12
Countries
United States
Sponsor
Ortho-McNeil Janssen Scientific Affairs, LLC

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.